With the analysis among 43,894 patents, we discovered top 455 key players by total patent application. Genentech, Inc., Novartis AG, F. Hoffmann-La Roche Ltd. are dominant in this area. They take 4.52% of the total patent filing.
California, United States
Patent: 742
Basel-Stadt, Switzerland
Patent: 662
F. Hoffmann-La Roche Ltd.
New York, United States
Patent: 489
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 348
California, United States
Patent: 335
Tokyo-to, Japan
Patent: 334
California, United States
Patent: 311
Hovedstaden, Denmark
Patent: 298
Illinois, United States
Patent: 291
With the analysis among 1,109 patents, we discovered top 97 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Biosion, Inc., Jiangsu Quanxin Biomedical Co Ltd are active in this area.
Institut National de la Santé et de la Recherche Médicale
Jiangsu Sheng, China
Patent: 54
Jiangsu Quanxin Biomedical Co Ltd
Jiangsu Sheng, China
Patent: 49
Verseau Therapeutics, Inc.
Massachusetts, United States
Patent: 40
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 33
Black Belt Therapeutics Ltd.
Herefordshire, United Kingdom
Patent: 29
Washington, United States
Patent: 26
California, United States
Patent: 19
Salubris Biotherapeutics, Inc.
With the analysis among related 11,527 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Alector, Inc., Regeneron Pharmaceuticals, Inc., Tianjin Lakeside Pangu gene science development Company Limited take 4.68% of patent filing during this period.
California, United States
Patent: 204
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 186
Tianjin Lakeside Pangu gene science development Company Limited
Tianjin Shi, China
Patent: 150
Zakrytoe Aktsionernoe Obshchestvo Biokad
Jiangsu Sheng, China
Patent: 146
New York, United States
Patent: 130
Basel-Stadt, Switzerland
Patent: 125
California, United States
Patent: 95
The Board of Regents of The University of Texas System
Texas, United States
Patent: 77
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 71
With the analysis among related 11,527 patents in last 5 years, we discover 139 new entrants. Biosion, Inc., Jiangsu Quanxin Biomedical Co Ltd, Verseau Therapeutics, Inc. are the most active new entrants in this area.
Jiangsu Sheng, China
Patent: 54
Jiangsu Quanxin Biomedical Co Ltd
Jiangsu Sheng, China
Patent: 49
Verseau Therapeutics, Inc.
Massachusetts, United States
Patent: 40
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Jiangsu Sheng, China
Patent: 38
Shanghai ChemExplorer Co., Ltd
Shanghai Shi, China
Patent: 35
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 33
Black Belt Therapeutics Ltd.
Herefordshire, United Kingdom
Patent: 29
Washington, United States
Patent: 26
Chengdu Bailidote Biological Pharmaceutical Co., Ltd.
Dirui Industrial Co., Ltd.
Jilin Sheng, China
Patent: 23
With the analysis among 14,032 patents, we discovered top 244 universities and scientific research institutions by total patent application. The Scripps Research Institute, Jiangnan University, The Trustees of Columbia University in The City of New York are dominant in this area. They take 9.42% of the total patent filing.
The Scripps Research Institute
California, United States
Patent: 246
Jiangsu Sheng, China
Patent: 246
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 181
Zhejiang Sheng, China
Patent: 168
Tennessee, United States
Patent: 125
North Carolina, United States
Patent: 120
Huazhong Agricultural University
Hubei Sheng, China
Patent: 115
The Johns Hopkins University
Pontificia Universidad Católica de Chile
New York, United States
Patent: 94